NIVOLUMAB-INDUCED MYASTHENIA GRAVIS WITH MYOCARDITIS AND MYOSITIS

被引：0
|
作者：
Tamkus, Greta
Boucekkine, Houda
Seibert, Katherine
Eng, Kevin
Betancourt, Jaime
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.2779
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4268A / 4269A
页数：2
相关论文
共 50 条
  • [21] Lymphocyte involvement in nivolumab-induced autoimmune myositis
    Koh, Benjamin
    Tuite, Kilian
    Khattak, Adnan
    Dyke, Jason M.
    PATHOLOGY, 2019, 51 (05) : 555 - 557
  • [22] Nivolumab-induced fatal myocarditis: A case report
    Bharathidasan, Kavya
    Abdelnabi, Mahmoud
    Abdelmalek, John
    Sekhon, Jasmine
    Butler, William
    Quirch, Miguel
    Sosa, Erwin Argueta
    CLINICAL CASE REPORTS, 2023, 11 (05):
  • [23] Durvalumab/Nivolumab/PembrolizumabGrade 3 Hepatitis, myositis and myasthenia gravis
    Reactions Weekly, 2024, 2006 (1) : 252 - 252
  • [24] Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies
    Kitazaki, Yuki
    Yamamura, Osamu
    Usui, Kojiro
    Ueno, Asako
    Sanada, Sayaka
    Sasaki, Hirohito
    Endo, Yoshinori
    Enomoto, Soichi
    Ikawa, Masamichi
    Nakamoto, Yasunari
    Hamano, Tadanori
    INTERNAL MEDICINE, 2023, 62 (20) : 3013 - 3020
  • [25] GIANT CELL MYOCARDITIS AND MYOSITIS - ASSOCIATED WITH THYMOMA AND MYASTHENIA GRAVIS
    BURKE, JS
    MEDLINE, NM
    KATZ, A
    ARCHIVES OF PATHOLOGY, 1969, 88 (04): : 359 - &
  • [26] Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: A case report
    Basnet, Arjun
    Sharma, Nava Raj
    Gautam, Sudarshan
    Lamichhane, Saral
    Kansakar, Sajog
    Tiwari, Kripa
    Pokhrel, Madalasa
    Singh, Sehajpreet
    CLINICAL CASE REPORTS, 2024, 12 (06):
  • [27] Nivolumab/pembrolizumabPneumonitis, myocarditis and myasthenia gravis: 2 case reports
    Reactions Weekly, 2021, 1873 (1) : 196 - 196
  • [28] Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in a patient with ureteral epithelial cancer
    Zhang, Jing
    Li, Jiayin
    Zhai, Linzhu
    Lin, Lizhu
    NEUROENDOCRINOLOGY LETTERS, 2021, 42 (06) : 383 - 386
  • [29] Nivolumab-induced myositis: A case report and a literature review
    Bourgeois-Vionnet, Julie
    Joubert, Bastien
    Bernard, Emilien
    Sia, Marie Angele
    Pante, Vanessa
    Fabien, Nicole
    Honnorat, Jerome
    Streichenberger, Nathalie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 387 : 51 - 53
  • [30] Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis
    Li, Meng-Ting
    He, Yang
    Huang, Si-Yong
    Hu, Xiao
    Chen, Ji-Sheng
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 116 - 126
12345